Blue Jet Healthcare Limited Stock

Equities

BLUEJET

INE0KBH01020

Pharmaceuticals

End-of-day quote NSE India S.E. 06:00:00 2024-05-15 pm EDT 5-day change 1st Jan Change
364.4 INR +0.05% Intraday chart for Blue Jet Healthcare Limited -4.11% -1.02%
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Last Hours!
Take advantage of the offer
* See conditions on site
Sales 2024 * 7.42B 88.94M Sales 2025 * 10.38B 124M Capitalization 63.2B 757M
Net income 2024 * 1.74B 20.82M Net income 2025 * 2.39B 28.65M EV / Sales 2024 * 8.14 x
Net cash position 2024 * 2.76B 33.11M Net cash position 2025 * 2.91B 34.86M EV / Sales 2025 * 5.81 x
P/E ratio 2024 *
36.4 x
P/E ratio 2025 *
26.4 x
Employees 407
Yield 2024 *
0.27%
Yield 2025 *
0.82%
Free-Float 14%
More Fundamentals * Assessed data
Dynamic Chart
1 day+0.05%
1 week-4.11%
Current month-6.05%
1 month-6.66%
3 months+6.75%
6 months-6.37%
Current year-1.02%
More quotes
1 week
361.85
Extreme 361.85
382.80
1 month
361.85
Extreme 361.85
407.00
Current year
324.00
Extreme 324
421.65
1 year
319.50
Extreme 319.5
433.40
3 years
319.50
Extreme 319.5
433.40
5 years
319.50
Extreme 319.5
433.40
10 years
319.50
Extreme 319.5
433.40
More quotes
Managers TitleAgeSince
Chief Executive Officer 30 15-12-07
Director of Finance/CFO - 21-10-31
Chief Tech/Sci/R&D Officer - 20-10-20
Members of the board TitleAgeSince
Director/Board Member 64 22-04-12
Director/Board Member 45 22-07-31
Director/Board Member 52 22-04-12
More insiders
Date Price Change Volume
24-05-16 364.4 +0.05% 59,454
24-05-15 364.2 -2.40% 125,336
24-05-14 373.1 +0.93% 39,917
24-05-13 369.6 -2.76% 125,480
24-05-10 380.2 +0.05% 122,164

End-of-day quote NSE India S.E., May 15, 2024

More quotes
Blue Jet Healthcare Limited is an India-based specialty pharmaceutical and healthcare ingredients and intermediates company. The Company’s operations are primarily organized in three product categories: contrast media intermediates, high-intensity sweeteners, and pharma intermediates and active pharmaceutical ingredients (APIs). Contrast media are agents used in medical imaging to enhance the visibility of body tissues under X-rays, computed tomography (CT), magnetic resonance imaging (MRI) or ultrasound. Its high-intensity sweetener business includes development, manufacturing and marketing of saccharin and its salts. The Company’s contract development and manufacturing organization (CDMO) activity in the pharma intermediate and API business is primarily focused on collaborating with innovator pharmaceutical companies and multi-national generic pharmaceutical companies by providing them with pharma intermediates that serve as building blocks for APIs in chronic therapeutic areas.
More about the company
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
3
Last Close Price
364.4 INR
Average target price
406.7 INR
Spread / Average Target
+11.61%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. BLUEJET Stock
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW